Stephen K. Klasko M.D.

CIK: 0001433241

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

DCGO

DocGo Inc.

Director

TFX

TELEFLEX INC

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

DCGO
DocGo Inc.
Sep 10, 2025
Award(A)
Direct
100K shares-
DCGO
DocGo Inc.
May 14, 2025
Purchase(P)
Direct
15K shares at avg. $1.49$22K
TFX
TELEFLEX INC
May 9, 2025
Award(A)
Direct
1.4K shares-
TFX
TELEFLEX INC
Feb 20, 2025
Exercise(M)
Direct
2.7K shares at avg. $121.00$324K
TFX
TELEFLEX INC
Feb 20, 2025
Tax Payment(F)
Direct
1.9K shares at avg. $174.82$324K
DCGO
DocGo Inc.
Nov 12, 2024
Award(A)
Options to purchase Common Stock
Direct
204.1K shares-

		Type	Shares	Price		Ownership
Sep 10, 2025	DCGO DocGo Inc.	Award(A)	100,000	-	-	Direct
May 14, 2025	DCGO DocGo Inc.	Purchase(P)	15,000	$1.49	$22,350	Direct
May 9, 2025	TFX TELEFLEX INC	Award(A)	1,357	-	-	Direct
Feb 20, 2025	TFX TELEFLEX INC	Exercise(M)	2,674	$121.00	$323,554	Direct
Feb 20, 2025	TFX TELEFLEX INC	Tax Payment(F)	1,851	$174.82	$323,592	Direct
Nov 12, 2024	DCGO DocGo Inc.	Award(A) Options to purchase Common Stock	204,082	-	-	Direct

1-6 of 6 transactions

About Klasko Stephen K. M.D.

Klasko Stephen K. M.D. (SEC CIK 0001433241) files insider reports with the SEC as Director of DocGo Inc. (DCGO) and Director of TELEFLEX INC (TFX).

Signal8 holds 6 ownership filings by Klasko Stephen K. M.D. (1 Form 3, 5 Form 4), filed between Oct 1, 2024 and Sep 11, 2025. Those filings report 6 transactions, from Nov 12, 2024 to Sep 10, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Klasko Stephen K. M.D.'s filings is in NEW YORK, NY.

Recent filings by Klasko Stephen K. M.D.

Sep 10, 2025: Grant or award of DCGO shares (Form 4, code A).
May 14, 2025: Open-market purchase of DCGO shares (Form 4, code P).
May 9, 2025: Grant or award of TFX shares (Form 4, code A).
Feb 20, 2025: Option exercise of TFX shares (Form 4, code M).
Feb 20, 2025: Tax withholding of TFX shares (Form 4, code F).

Other insiders filing for DocGo Inc. (DCGO)

Bienstock Lee, Chief Executive Officer
ROSENBERG NORMAN, CFO and Treasurer
Sugrue Stephen, Chief Compliance Officer
Tendler Ely D, General Counsel and Secretary
Burdiek Michael J, Director
Leite Etalvina, Director

How to read Form 4 transaction codes